Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin add-on to metformin in T2DM
NCT00822211Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Dec 2008; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00822211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822211.